Exchange: NASDAQ·Updated 10:39 AM EDT

ANEB Anebulo Pharmaceuticals Inc

$0.295
$0.2943
(42042.86%)
Today
Reported EarningsFeb 12
Mkt Cap$28,549.00
Vol100.00

About ANEB

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
47

Neutral Sentiment

How do you feel about ANEB?

Advertisement|Remove ads.